New hope for cancer pain: drug combo aims to cut suffering
Symptom relief
Not yet recruiting
This study tests whether adding a new drug (3D1002) to a standard painkiller (oxycodone) can better control moderate to severe cancer pain. About 177 adults with cancer and ongoing pain will receive either the combination or standard treatment. The goal is to see if the new appro…
Phase: PHASE2 • Sponsor: 3D Medicines • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC